FLUORESCENT IN SITU HYBRIDISATION POSITIVE

FLUORESCENT IN SITU HYBRIDISATION POSITIVE was reported 10 times

FLUORESCENT IN SITU HYBRIDISATION POSITIVE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 NADOFARAGENE FIRADENOVEC-VNCG 1 0.0019
1 BOSUTINIB 1 0.0001
2 NILOTINIB 2 0.0001
3 MERCAPTOPURINE 1 0.0001
4 ERGOCALCIFEROL 1 0.0000
5 FLUOROURACIL CREAM, 0.5% 2 0.0000
6 FLUOROURACIL 2 0.0000
7 ADALIMUMAB-FKJP 1 0.0000
8 ADALIMUMAB-AATY 1 0.0000
9 PACLITAXEL 2 0.0000
10 ADALIMUMAB-ADAZ 1 0.0000
11 CARBOPLATIN 2 0.0000
12 DOCETAXEL 1 0.0000
13 DOCETAXEL ANHYDROUS 1 0.0000
14 CIPROFLOXACIN TABLETS 1 0.0000
15 ETOPOSIDE 1 0.0000
16 OXALIPLATIN 1 0.0000
17 VEDOLIZUMAB 1 0.0000
18 CIPROFLOXACIN HYDROCHLORIDE 1 0.0000
19 USTEKINUMAB 1 0.0000
20 CYCLOPHOSPHAMIDE FOR INJECTION 1 0.0000
21 CYCLOPHOSPHAMIDE 1 0.0000
22 PREDNISOLONE ORAL SOLUTION 1 0.0000
23 LENALIDOMIDE 1 0.0000
24 OMEPRAZOLE MAGNESIUM 1 0.0000
25 PREDNISONE 1 0.0000
26 ADALIMUMAB 1 0.0000